China Botanic Pharmaceutical (CBP) Reports Q1 Earnings of $0.33/Share; Reaffirms Outlook

China Botanic Pharmaceutical (NYSE: CBP) reported Q1 EPS of $0.33, versus $0.29 reported last year. Revenue for the quarter came in at $28.1 million, versus $22.6 million reported last year.

China Botanic Pharmaceutical reaffirmed FY2012 guidance.

For earnings history and earnings-related data on China Botanic Pharmaceutical (CBP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
• JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight
• ITG (ITG) Tops Q2 EPS by 1c